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Abstract
Purpose: There is a need for bedside methods to monitor oxygen delivery in the microcirculation. Near-infrared spectroscopy commonly measures tissue oxygen saturation, but does not reflect the time-dependent variability of microvascular
hemoglobin content (MHC) that attempts to match oxygen supply with demand. The objective of this study is to determine
the feasibility of MHC monitoring in critically ill patients using high-resolution near-infrared spectroscopy to assess perfusion in the peripheral microcirculation. Methods: Prospective observational cohort of 36 patients admitted within 48 h at
a tertiary intensive care unit. Perfusion was measured on the quadriceps, biceps, and/or deltoid, using the temporal change
in optical density at the isosbestic wavelength of hemoglobin (798 nm). Continuous wavelet transform was applied to the
hemoglobin signal to delineate frequency ranges corresponding to physiological oscillations in the cardiovascular system.
Results: 31/36 patients had adequate signal quality for analysis, most commonly affected by motion artifacts. MHC signal
demonstrates inter-subject heterogeneity in the cohort, indicated by different patterns of variability and frequency composition. Signal characteristics were concordant between muscle groups in the same patient, and correlated with systemic
hemoglobin levels and oxygen saturation. Signal power was lower for patients receiving vasopressors, but not correlated
with mean arterial pressure. Mechanical ventilation directly impacts MHC in peripheral tissue. Conclusion: MHC can be
measured continuously in the ICU with high-resolution near-infrared spectroscopy, and reflects the dynamic variability of
hemoglobin distribution in the microcirculation. Results suggest this novel hemodynamic metric should be further evaluated
for diagnosing microvascular dysfunction and monitoring peripheral perfusion.
Keywords Microcirculation · Near-infrared spectroscopy · Hemodynamic monitor · Critical care · Wavelet analysis

1 Introduction
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[1]. Perfusion status correlates better with ICU outcomes
than macro-hemodynamics [2, 3], and there is emerging
study of perfusion-guided resuscitation using clinical
indicators such as capillary refill time, skin mottling, and
body temperature gradients [4, 5]. Although these measurements can be standardized, they are often subject to
inter-observer variability and lack refinement beyond rudimentary measures.
Microvascular monitoring has been proposed as an
adjunct strategy for quantifying peripheral perfusion in
the ICU [6, 7]. Near-infrared spectroscopy (NIRS) can be
applied continuously and non-invasively to measure tissue
oxygen saturation (StO2) of hemoglobin in skeletal muscle
and overlying tissue [8]. Since venules contain the majority of blood in the microcirculation, StO2 can be viewed
primarily as a measure of regional venous oxygen saturation [9]. However, a recent randomized controlled trial
did not show benefit for incorporating S
 tO 2 in a sepsis
protocol [10], suggesting this may not be the correct target
for microvascular resuscitation.
There is a need for physiologically-informed methods
for evaluating the peripheral microcirculation that describe
the dynamic process of oxygen delivery in microvascular networks. Traditionally, NIRS considers two distinct
hemoglobin chromophores: oxy- (Hb-O 2 ) and deoxy(Hb) hemoglobin, with the sum of both chromophores
denoted as total hemoglobin (HbT) [11]. Changes in HbT
are proposed as a surrogate for changes in blood volume,
assuming incorrectly that the microcirculation has a fixed
hematocrit [12, 13]. In reality, red blood cells (RBCs)
do not exist in exclusively oxy/deoxy states and contain
millions of hemoglobin proteins with an aggregate RBC
oxygen saturation. Furthermore, hematocrit and RBC flow
in microvascular networks are highly heterogeneous [14],
and temporal variations in HbT reflect changes in blood
volume, hematocrit, and flow velocity within all three
microvascular compartments (arterioles, capillaries, and
venules) [8, 15].
We propose microvascular hemoglobin content (MHC)
to denote the total hemoglobin contained in all the RBCs
in the microcirculation. Although technically equivalent to
HbT, the distinction arises from how this measurement is
evaluated as a time-dependent physiological variable. MHC
variability represents the continuous process of RBC distribution that is regulated within the underlying microcirculation, and we hypothesize that MHC may serve as a novel
hemodynamic metric for monitoring microvascular function
in the ICU. The goal of the current study is to (i) outline
the theory and rationale for the technology, (ii) evaluate the
feasibility of signal acquisition and signal analysis in the
intended clinical environment, and (iii) present the findings
of this pilot cohort with an emphasis on signal characterization and descriptive statistics.
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2 Methods
2.1 Study details
This is a prospective observational cohort study. Patients
were recruited in a tertiary adult medical-surgical ICU
(July 2017–April 2019) and all research practices were
performed in accordance with institutional ethics protocol
and approval (REB #108760). Participants were recruited
within 48 h of admission to the ICU, and consent was
obtained from the patient or substitute decision maker
prior to commencement of the study. The NIRS system
was applied to the quadriceps, biceps, and/or deltoid; additional protocol information can be found in supplementary
content. This was a one-time observational study, with
no additional follow-up or intervention other than MHC
monitoring.

2.2 High‑resolution NIRS for measuring
microvascular hemoglobin content
Microvascular hemoglobin content (i.e. HbT concentration) is derived from NIRS signal sampled at high temporal resolution (10 Hz). For most NIRS wavelengths, variations in hemoglobin concentration (HbT) or saturation
( StO 2) can both affect tissue absorption. The isosbestic
wavelength of hemoglobin defines the wavelength with
identical extinction coefficients for Hb-O2 and Hb; in
the near-infrared spectrum this occurs at approximately
798 nm [16]. Therefore, changes in tissue absorbance at
the isosbestic wavelength only detect variations in HbT
concentration [11, 12]. In this study, MHC variability was
measured using isosbestic NIRS, and can equally be calculated with two wavelengths to derive HbT as the sum of
Hb-O2 and Hb hemoglobin chromophores [12].
This time-dependent HbT measurement also accounts
for the contribution of melanin and myoglobin, that significantly affect NIRS absorption in peripheral tissue [17].
Because melanin and myoglobin have fixed tissue concentrations, they do not contribute to the temporal variability
in NIRS signal [8]; myoglobin saturation may vary within
skeletal muscle, but the concentration is static. Thus, highresolution NIRS specifically measures the temporal change
in hemoglobin content, as a surrogate for RBC flow within
the underlying microcirculation.

2.3 Engineering and system details
Measurements were acquired with a continuous-wave
broadband NIRS system based on a modified off-the-shelf
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spectrometer (QE65000 Ocean Optics, Dunedin, FL) and
a halogen lamp (Ocean Optics HL-2000-HP). Technical
specifications and proof-of-concept of the NIRS system
have been described previously [18].
Data capture was performed using SpectraSuite™ software (Ocean Optics, Inc.). Light intensities were recorded
at the isosbestic wavelength 798 nm with a sampling frequency of 10 Hz (100 ms integration time). Source detector
distance (SDD) was 20 mm (7 participants) and 15 mm (29
participants). Shorter SDD interrogates a smaller volume of
tissue and depth of penetration, but with higher light intensities recovered by the spectrometer; this modification was
made when very low intensity signal was encountered for
one patient early in the cohort.
Light intensity is converted to change in optical density
(ΔOD) as follows:
( )
I to
ΔOD(t) = log10
I(t)

the sum over the frequency range. B1 (ultra-low frequency)
and B6 (high frequency) were removed from the analysis
as they were most susceptible to artifacts, as described
in supplementary content. Thus, the final CWT signal is
defined from B2–B5 and comprises three microvascular
bands B2–B4 and the respiratory band B5. Using CWT,
total signal power B2–B5 and for each frequency band is
represented with mean, median, and coefficient of variation
(%CV) over the duration of the recording; median power was
the metric most often used for analysis in this study, being
less impacted by extreme values than the mean. When applicable, CWT measurements were averaged for each muscle
site, and muscle sites were averaged to calculate summary
values for each patient.
The percentage contribution (%Power) of each frequency
band relative to the total signal power was also quantified.
For example, %Power of the respiratory band B5 is calculated as:

where I(to) is the initial intensity at time = 0, and I(t) is the
intensity at any subsequent time, t.
Assuming that tissue scattering does not change during
the recording, ΔOD measures the change from baseline in
HbT concentration in arbitrary units [19].
ΔOD time series (i.e. MHC tracings) were screened manually for artifacts as described in supplementary content and
supplementary Fig. 1. Only continuous tracings of greater
than 5 min with adequate signal quality were included in
the analysis.

%PowerB5 =

2.4 Continuous wavelet transform (CWT)
Application of continuous wavelet transform (CWT) for
analysis of cardiovascular time series was first described by
Stefanovska and colleagues [20], and has gained widespread
use in the field of laser doppler flowmetry (LDF) of human
skin [21, 22]. CWT is an attractive tool, as it provides good
localization of signal in both time and frequency for nonstationary data. Using CWT, time series can be represented
as power versus frequency versus time for physiological
oscillations ascribed to components of the cardiovascular
system [23]. Six “frequency bands” have been derived from
pharmacological iontophoresis studies of human skin, and
are proposed to represent mechanisms of peripheral and
central blood flow control [21, 23–25] (Table 1): (1) B1
metabolic (2) B2 endothelial (3) B3 neurogenic (4) B4 myogenic (5) B5 respiratory (breath rate) and (6) B6 cardiac
(heart rate).
CWT analysis was applied in this study to ΔOD time
series using the Morlet wavelet in Matlab v2016b (Fig. 1).
The total power for each frequency band was computed as

median PowerB5
× 100
median PowerB2 − B5

This represents the contribution from the respiratory
frequency range (0.16–0.667 Hz) to the total signal power.
Similar calculations are used to quantify the contribution of
frequency bands relative to the microvascular signal B2–B4.

2.5 Statistical analysis
Statistical analysis was performed using PRISM v8 software
package. Lognormal distribution of median power values
was assessed with D’Agostino Pearson test, with subsequent
analysis performed using parametric tests on -logtransform
of median power. Concordance between median power
for frequency bands in the same patient was tested with a
Pearson correlation matrix. Correlation between different
muscle sites in the same patient was assessed with Pearson
and Spearman correlation coefficient (r) for median power
and %Power, respectively. MHC signal power was compared between patients requiring and not requiring vasoactive medication (vasopressors), patients with serum lactate
greater or less than 2.0 mmol/L, and between SDD configurations using Student’s unpaired t-test; %CV was compared
between patients requiring and not requiring vasopressors
using Mann–Whitney U test. Linear regression was used
to calculate the coefficient of determination ( R2) between
MHC signal power and systemic variables: mean arterial
pressure (MAP), serum hemoglobin concentration ([Hb],
g/L), arterial oxygen saturation (SpO2, %), and serum lactate (mmol/L).
Linear regression was used to assess correlation between
MHC respiratory power B5 and %Power B5, and ventilator
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Fig. 1  Application of continuous wavelet transform (CWT) to microvascular hemoglobin content (MHC) time series in peripheral tissue
for continuous perfusion monitoring. 15 min of data is shown for two
patients with cardiac arrest (upper) and sepsis (lower). MHC variability is defined as the change from baseline in total hemoglobin concentration, measured at high temporal resolution (10 Hz) with isosbestic
near-infrared spectroscopy (ΔOD, arbitrary units). MHC time series
demonstrates substantial temporal variability, as well as differences
in variability patterns between patients. Data is represented with

standard time series (MHC vs time), CWT time–frequency projection
(power vs frequency vs time), and the global wavelet power spectrum
(GWPS) averaged over the recording (power vs frequency). Dotted
line in the CWT indicates data outside the cone of influence that is
susceptible to edge effects. Dashed lines in the GWPS represent the
boundaries of the frequency bands used for analysis in this study (B1
metabolic, B2 endothelial, B3 neurogenic, B4 myogenic, B5 respiratory, B6 cardiac)

parameters—positive end-expiratory pressure (PEEP), driving pressure (ΔP), and tidal volume (Vt); tidal volume was
measured as an index of body weight (cc/kg). These relationships were subsequently evaluated with multivariate regression to control for any interactions.

3 Results
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3.1 Feasibility metrics from the pilot cohort
36 patients were recruited for the study with mean recording time 101.50 ± 50.12 min (range: 0.00–221.10) per
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Table 1  Frequency bands used in the present study, that are attributable to physiological oscillations in the cardiovascular system [23, 24,
43]
Frequency band

Frequency (Hz) Period (seconds) Cycles/minute

B0
B1—Metabolic
B2—Endothelial
B3—Neurogenic
B4—Myogenic
B5—Respiratory
B6—Cardiac

0–0.005
0.005–0.0095
0.0095–0.02
0.02–0.06
0.06–0.16
0.16–0.667
0.667–3.1

> 200
105.3–200
50–105.3
16.67–50
6.25–16.67
1.5–6.25
0.32–1.5

< 0.3
0.3–0.57
0.57–1.2
1.2–3.6
3.6–9.6
9.6–40
40–186

Frequency ranges are adapted from previous studies [21, 25], with
modification to the upper limit of respiratory band to include rapid
breathing rates observed in the ICU
Table 2  Demographics for the patients in the final dataset included
for analysis (n = 31). Data are represented as mean ± SD, median
(IQR), or percentage of total cohort
N = 31 patients
Age (years)
Male (%)
Weight (kg)
MAP (mmHg)
HR (bpm)
Sepsis (%)
Cardiac arrest (%)
Vasopressors (%)
Mechanical ventilation (%)
FiO2
SpO2%
PEEP (cm H
 20)
Lactate (mmol/L)
[Hb] (g/L)

62.10 ± 16.55
61.3
82.12 ± 17.67
75.30 ± 12.73
83.32 ± 15.68
35.5
19.4
64.5
90.3
0.40 (0.2)
97 (3.5)
10 (4)
1.4 (0.8)
95 (34.5)

MAP mean arterial pressure, HR heart rate, FiO2 fraction of inspired
oxygen, SpO2 arterial oxygen saturation, PEEP positive end-expiratory pressure, [Hb] systemic hemoglobin concentration

patient. After manually screening for signal quality and
artifacts, the final data set comprised 31 patients with
a mean recording time of 74.02 ± 36.89 min (range:
5.83–148.70). Demographics for the final study cohort are
provided in Table 2. Signal quality for the final cohort was
high, with median 74% (IQR 54–88) of recorded signal
suitable for analysis; the most common reason for signal degradation was motion artifact. Of the five patients
unsuitable for analysis, two were excluded due to measurements with compression stockings (this was a naïve error
early in the study, but did demonstrate the venous occlusion waveform included in the supplementary content);
one patient was excluded due to insufficient signal intensity (SDD of the NIRS system was subsequently modified,

1457

as described in methods); one patient was recruited but
could not be measured due to clinical circumstances; and
one patient was excluded due to excessive motion artifacts.
MHC tracings were recorded from 54 muscles with a
mean duration of 42.49 ± 22.34 min (range: 5.50–93.66)
per muscle. 20/31 patients had recordings from multiple
muscle sites, including three patient with recordings from
3 muscle sites. The main limitations for measuring multiple muscle sites was the presence of compression stockings
on the lower extremities, patient positioning, lines and tubing, and change in clinical condition. Vastus medialis and
biceps were the most common muscle sites for recording,
and easiest to measure with patient positioning and clinical
workflow; the deltoid muscle site was most vulnerable to
motion artifacts and vastus lateralis was suboptimal due to
patient positioning.

3.2 MHC signal demonstrates non‑stationary
temporal dynamics and inter‑subject
heterogeneity
Figure 1 illustrates 15 min of continuous MHC tracings,
CWT projection, and global wavelet power spectrum
(GWPS) for 2 patients in the cohort (cardiac arrest and
sepsis). MHC signal demonstrates biological variability
and complexity, and the pattern of MHC variability is not
similar for these patients. Using CWT, the time-dependent
changes in MHC power at various frequencies is illustrated,
and the CWT projections are distinctive between subjects.
The cardiac arrest MHC tracing demonstrates a combination of fast and slow frequency components with no discernable pattern throughout the recording; this is reflected in the
GWPS with balanced distribution of power throughout the
microvascular bands. By contrast, the sepsis MHC tracing
is dominated by a slow, periodic and persistent oscillation
with occasional episodes of correction—a phenomenon that
has been described as vasomotion [26]. In the GWPS, this
is represented by a singular broad peak in the neurogenic
frequency band.
Median power, %Power, and %CV for MHC signal for
the 31 patients in the final dataset is reported in Fig. 2.
Median power values in the cohort follow a lognormal
distribution (p > 0.05, D’Agostino Pearson test). MHC
signal demonstrates substantial temporal variability,
represented by the %CV of signal power versus time
(Fig. 2b). Correlation matrix for the frequency bands is
shown in supplementary Fig. 2; microvascular frequency
bands B2–B4 are more closely correlated with each other
than the respiratory band B5. There was no significant
difference in signal power between SDD 15 mm and
20 mm (4.957 vs 4.733, p = 0.2019).
The %Power composition of MHC signal for each
patient is shown in Fig. 3 and is not consistent across
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Fig. 2  MHC signal characteristics for the patients included in the
final cohort (n = 31 patients), reported for total signal B2–B5 and
for each frequency band (B2 endothelial, B3 neurogenic, B4 myogenic, B5 respiratory). a MHC median power values for patients in
the cohort follows lognormal distribution (p > 0.05, D’Agostino Pear-

son test). b Temporal variation in each frequency band, expressed as
coefficient of variation (%CV) of signal power vs time. c Percentage
contribution (%Power) for each frequency band relative to total signal power B2–B5, calculated as (median Power band / median Power
B2–B5)

the cohort. There is varying contribution to the overall
MHC power from the microvascular bands B2–B4 versus
respiratory band B5 (Fig. 3a). Furthermore, the proportions of each band within the microvascular signal B2–B4
is not consistent (Fig. 3b); some patients have balanced
power between all three bands, while others have two or
even one frequency component that dominates the signal
composition.

with ΔOD time series for three patients (Fig. 4): the respiratory frequency is superimposed on the intrinsic variability
of each MHC tracing. Similarly, CWT projection (Fig. 1)
identifies the ventilator effect as a distinct power stripe in
the respiratory band B5.
Linear regression shows a positive correlation between
Power B5 and tidal volume (Supplementary Figure S6a;
R2 = 0.22, p = 0.0141), but no correlation with PEEP or
driving pressure (p > 0.05). %Power B5 is positively correlated with PEEP (Supplementary Figure S6b; R2 = 0.25,
p = 0.0065), but no correlation with tidal volume or driving
pressure (p > 0.05). These findings persisted with multivariate regression (supplementary Table 2).

3.3 MHC signal characteristics are concordant
between muscle groups in the same patient
and positively correlated with systemic
hemoglobin and oxygenation levels
Pairwise comparison for signal power between muscle
sites in the same patient demonstrates moderate correlation for microvascular bands B2–B4 (Supplementary
Figure S3; r = 0.52–0.68, p < 0.05), but not for respiratory B5. %Power was moderately correlated between muscle sites in all frequency bands (Supplementary Figure
S4; r = 0.48–0.73, p < 0.05). MHC microvascular power
B2–B4 is positively correlated with systemic hemoglobin
levels (Supplementary Figure S5a; R
 2 = 0.24, p = 0.0055)
and with S pO 2 (Supplementary Figure S5b; R 2 = 0.15,
p = 0.0410).

3.4 Mechanical ventilation directly impacts MHC
in peripheral tissue
Respiratory frequency from the ventilator was readily
detectable with MHC monitoring in this cohort. The effect
of mechanical ventilation on MHC signal is demonstrated
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3.5 MHC signal power is differentiated according
to vasopressor status, but not mean arterial
pressure or lactate
Vasopressor use was required in 20/31 patients (64.5%) in the
cohort. Patients receiving vasopressors had significantly lower
MHC signal power B2–B5 when compared to patients not
receiving vasopressors (Fig. 5a; 5.023 vs 4.715, p = 0.0286),
but there was no correlation between signal power and MAP
(Fig. 5b; R2 = 0.02, p = 0.4384). There was no difference in
temporal variability (%CV) of MHC signal between vasopressor groups (46.1 vs 38.6, p = 0.8870). Median serum lactate in
the cohort was 1.4 (IQR 1.0–1.8) mmol/L, with 6/31 patients
(19.4%) having lactate values greater than 2.0 mmol/L. Serum
lactate was not correlated with MHC signal power (R2 = 0.04,
p = 0.2600), and there was no difference in signal power
between patients with lactate greater or less than 2.0 mmol/L
(5.133 vs 4.991, p = 0.5591).
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Fig. 3  Signal power composition for each patient (n = 31) demonstrates the percentage contribution (%Power) from each frequency
band relative to overall signal power (B2 endothelial, B3 neurogenic,
B4 myogenic, B5 respiratory). %Power composition is not consistent
between patients in the cohort. a %Power for microvascular bands

B2–B4 and respiratory band B5 relative to overall signal B2–B5;
%Power is calculated as (median Power/median Power B2–B5). b
%Power for each microvascular band relative to microvascular signal
B2–B4; %Power is calculated as (median Power/median Power B2–
B4)

4 Discussion

peripheral tissue in the ICU, representing a novel method for
quantifying microvascular hemodynamics.
The main goal of this pilot study was to assess feasibility for MHC monitoring in the ICU, that was successfully
demonstrated by signal acquisition from the large majority
of patients in the cohort; the number of recruited patients
that were invalidated was low, and for reasons that are easily
corrected. Moreover, MHC signal quality was high, with a
large majority of recorded data suitable for analysis. Motion
artifacts were notable, but can been minimized in the future,
as with other continuous physiological waveforms including pulse oximetry [28], cardiac telemetry [29], and arterial

This pilot study demonstrates that MHC monitoring in the
ICU can provide continuous physiological data for assessing
peripheral perfusion. Using high-resolution data sampling
and a straightforward optical device, a signal with substantial biological variability was measured. Fundamentally, this
variability underscores the physiology of RBC distribution,
and should be viewed as the primary method by which oxygen delivery is regulated in the microcirculation [27]. Moreover, this is the first application of CWT to NIRS data from
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Fig. 4  High-resolution NIRS demonstrates the interaction between
mechanical ventilation and MHC signal in peripheral tissue. MHC
time series (ΔOD, arbitrary units) for three patients are shown. The
mechanical ventilator is evident as a distinctive “saw-tooth” pattern

superimposed on the intrinsic variability of the MHC signal. The frequency corresponds to the respiratory rate (RR, breaths per minute)
delivered by the mechanical ventilator

Fig. 5  MHC signal power is differentiated according to vasopressor status, but is not correlated with mean arterial pressure. Note the
-logtransform data where lower values indicate higher MHC signal
power. MAP mean arterial pressure. a MHC signal power B2–B5 is

significantly reduced for patients receiving vasopressors (*p = 0.0286,
Student’s unpaired t-test). Lines represent mean and standard deviation. b MHC signal power B2–B5 is not correlated with mean arterial
pressure

blood pressure [30]. Overall, this pilot study supports ongoing clinical investigation of MHC monitoring.
Tools for quantifying peripheral perfusion in the ICU
have emerged in recent decades, as technology has made
bedside evaluation of the microcirculation more accessible.
Sublingual microcirculation has been evaluated extensively
using handheld videomicroscopy [31], and alterations to
the microvascular perfusion characteristics are seen following ICU interventions [32–35], and correlated with adverse
ICU outcomes [36, 37]. Dynamic assessments of peripheral perfusion using LDF [38, 39] or StO2-derived vascular
occlusion tests [40, 41] also correlate with ICU outcomes,

signifying the importance of the microcirculation in the
pathophysiology of critical illness.
The strength of this current study is the simple application of this non-invasive optical technology, that may facilitate the adoption of MHC for monitoring deep tissue perfusion in many clinical settings. MHC is measured with NIRS
using one or two wavelengths and well-accepted biomedical
optics equations; the only requirement is high temporal resolution. MHC is recorded at the bedside in a similar fashion to
cardiac telemetry and pulse oximetry, and is operator independent. In contrast, laser doppler and sublingual systems
monitor only superficial tissue beds, and require training
for data collection and analysis; they are also not conducive
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to continuous real-time monitoring in a challenging ICU
environment.
This pilot study introduces MHC as a novel continuous
hemodynamic metric with substantial biological variability and signal complexity (Fig. 1). These patterns of variability relate to the spatial and temporal complexity of the
cardiovascular system that integrates signals from central,
local, and neurogenic mechanisms. Time–frequency analysis
using CWT highlights the presence of coupled oscillators
that produce MHC time series with non-stationary and nonlinear dynamics [42, 43]. These features are evident with
high-resolution MHC data sampled at 10 Hz, but are often
overlooked when measuring StO2 with commercial NIRS
systems that report values every 2–5 s. Furthermore, given
the slower change of StO2 in skeletal muscle (i.e. regional
venous oxygen saturation), S
 tO2 functions mostly as a trend
monitor over minutes to hours rather than second-to-second
variability as observed with MHC.
MHC analysis in Fig. 3 indicates that the signal composition (%Power from each frequency band) is not consistent between patients, and that physiological heterogeneity
may exist regarding peripheral perfusion characteristics;
this is not surprising in a cohort of patients with complex
and diverse ICU diseases. Sub-classification according to
physiological profile has been proposed for sepsis using
organ failure models [44, 45], lactate kinetics [46], body
temperature [47], and continuous vital signs [48, 49]. These
subclasses (endotypes) have identified groups with differing
mortality risks and treatment response profiles. By incorporating signal from the peripheral microcirculation, MHC
may eventually delineate physiological endotypes of perfusion that are not evident with macro-hemodynamic monitors.
This study suggests that MHC signal power may discriminate between patients according to vasopressor status but
not according to MAP (Fig. 5). This is consistent with prior
studies that noted vasopressor use was a better surrogate for
microvascular injury than MAP or cardiac index [36]. MHC
power was lower for patients receiving vasopressors, and
may reflect reduced oxygen delivery consistent with computational models [50]. The relationship between systemic
hemodynamics and the microcirculation is disrupted in critical illness [51], and disparities often exist between macrohemodynamics and the degree of microvascular injury [37,
52]. The absence of correlation between MAP and MHC is
consistent with the concept of the microcirculation as a distinct hemodynamic compartment, and the inability for systemic parameters to predict microvascular status. The lack
of correlation between MHC and lactate may reflect the fact
that most patients had normal lactate levels (< 2.0 mmol/L)
at the time of monitoring, but also the differential kinetics
between lactate clearance and microvascular perfusion [53].
These findings support the application of microvascular
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monitoring to enhance the hemodynamic management of
patients with circulatory failure.
The interaction between mechanical ventilation and the
circulatory system is well-described for the macrocirculation, but rarely has this impact been considered for the
microcirculation. Using high-resolution NIRS, this study
is the first to describe this phenomenon in skeletal muscle (Fig. 4). Respiratory-induced intensity variation with
mechanical ventilation has been demonstrated with cerebral NIRS to measure regional venous saturation [54],
and with pulse oximetry as a marker of volume responsiveness [55]. It is postulated that positive pressure decreases
venous return and causes expansion of blood volume in the
peripheral venous compartment [54, 56]. Measured here in
another vascular bed, these findings support the hypothesis
that mechanical ventilation is exerting a systemic impact
on the microcirculation of many organs throughout the
body. MHC monitoring directly quantifies the magnitude
of hemoglobin content displaced by mechanical ventilation
in peripheral microvascular networks, that will depend on
the interaction between ventilator parameters, pulmonary
mechanics, and venous hemodynamics (e.g. central venous
pressure, blood volume, flow, capacitance). At this stage,
it is unclear whether this phenomenon has any direct consequences on organ function, or the mechanisms through
which these consequences could be mediated.
MHC signal is comparable in different muscle groups
for the same patient (supplementary Figs. 3 and 4), suggesting a connection between central and peripheral blood
flow control mechanisms throughout the body. Some of the
concordance between muscle groups will arise from central signals that impact the entire system (e.g. heart rate,
mean arterial pressure), but there are also semi-centralized
mechanisms that operate throughout vascular networks (e.g.
sympathetic tone). B2 endothelial and B3 myogenic bands
are ascribed to local mechanisms of blood flow control, that
may be similarly affected by systemic critical illness across
the spatially distributed peripheral compartment.
Systemic hemoglobin and oxygenation levels are positively correlated with MHC microvascular signal power
(Supplementary Figure S5), although these findings should
not be overstated in a pilot cohort. It is well known from preclinical studies that the ‘network Fahreaus effect’ explains
the reduction in microvascular hematocrit compared with
systemic hematocrit [57]; however, the relationship between
systemic and microvascular hematocrit during interventions
(e.g. experimental hemodilution) is not always straightforward [58]. In translational human studies, a NIRS-derived
index of tissue hemoglobin was not correlated with systemic
hemoglobin [59], and RBC transfusion has a variable impact
on NIRS and sublingual microvascular perfusion [60, 61].
Because MHC measures the temporal change in hemoglobin
content within the underlying tissue, it may track better
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with RBC flux and systemic hemoglobin levels. Reduction
in signal power with decreasing arterial oxygen saturation
may reflect a microvascular system with diminished physiological reserve [62]. These relationships and the possible
impact of RBC transfusion on MHC signal require further
exploration.

4.1 Study limitations and future considerations
The main technical limitation for the NIRS system used in
the study is the contribution from superficial tissue to MHC
signal with SDD 15 mm and 20 mm, and the variable depth
of tissue penetration with these configurations; similarly adipose tissue thickness was not directly measured, but attempts
were made to minimize this source of error with patient
selection (BMI < 35) and probe positioning. Superficial contamination is a concern with NIRS, where discrepancies in
oxygen metabolism and blood flow can exist between skin,
adipose, and skeletal muscle [8]. Between these three tissues, skeletal muscle comprises the largest vascular bed with
the greatest contribution to MHC variability. In this cohort,
there was no difference for MHC signal power between the
two SDD configurations, and CWT coherence is noted in
prior studies for simultaneous measurements from skin with
laser doppler and skeletal muscle with NIRS [63, 64]. This
suggests MHC variability may be a more uniform metric
across tissue layers, and supports the application of CWT
in the current study. The decision to shorten SDD in this
study was driven by technical considerations relating to
sensitivity of the spectrometer, rather than overall concerns
with the application of the technology. The contribution and
coherence of MHC signal from superficial and deep layers of
peripheral tissue can be further characterized with spatiallyresolved NIRS in future system iterations.
As illustrated with CWT projection in Fig. 1, there is a
clear demarcation of the respiratory band B5, yet the boundaries between microvascular frequency bands B2–B4 used
from previous studies seem arbitrary; the GWPS also shows
that the spectral peaks for these oscillators can fall outside
of their intended band. Although these frequency components have been defined in previous studies and ascribed to
regulatory systems [21, 25], their origins are proposed from
indirect evidence and the underlying physiology of these
oscillations is not well established [26]. Furthermore, some
MHC tracings had a detectable heart rate, although this was
not a consistent finding for most patients or recordings (data
not shown). Overall, the results of this pilot study suggest
that further work is needed to understand the true origins
of these oscillations, how to measure them in the peripheral microcirculation, and how best to represent them using
time–frequency projections.
Building on the findings of this pilot study, more work is
needed to characterize the interactions between MHC and
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systemic hemodynamics. Using high-resolution NIRS, correlations between MHC and MAP can be investigated as
continuous physiological waveforms, similar to the analysis
developed for cerebral autoregulation [13]; systemic hemodynamic assessment can also include echocardiography
or other non-invasive measures of cardiac output. Moreover, controlled studies can determine the effect of hemodynamic interventions (e.g. fluid bolus, MAP changes) on
MHC signal. This current study demonstrates the impact of
mechanical ventilation on peripheral tissue, and suggests
that ventilator parameters may influence signal characteristics (Supplementary Figure S6). Future work should relate
MHC signal to the hemodynamic effects of mechanical ventilation that have been used as a marker of fluid responsiveness (e.g. pulse pressure variation) [65].
Most importantly, while this pilot study demonstrates
the feasibility of MHC monitoring in the ICU, it does not
evaluate the efficacy of MHC as a diagnostic or prognostic
tool. Given the substantial between-patient heterogeneity
observed in this cohort, larger sample sizes will be required
with the addition of healthy volunteers as a comparison
group; MHC signal complexity also suggests that the best
metrics for characterizing microvascular dysfunction are
not yet established. Furthermore, studies have shown that
microvascular monitoring may not discriminate between survivors and non-survivors during initial evaluation, and that
metrics will only separate later in ICU stay [41, 66]. Thus,
the prognostic ability of MHC monitoring is best evaluated
with daily assessment to correlate MHC signal with ICU
outcomes. This information is a pre-requisite before any consideration for incorporating MHC as a resuscitation target.
Overall, the findings from this pilot study have provided vital
information regarding the nature of this novel hemodynamic
signal, and will allow better refinement of system engineering, monitoring strategy, and the ability to successfully test
numerous hypotheses in future studies.

5 Conclusions
Microvascular hemoglobin content in peripheral tissue can
be measured continuously in the intensive care unit with
high-resolution NIRS and reflects the dynamic variability of
hemoglobin distribution in the microcirculation. Mechanical ventilation directly impacts MHC in peripheral tissue.
Results suggest that this novel hemodynamic metric should
be further evaluated for diagnosing microvascular dysfunction and monitoring peripheral perfusion.
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